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Background: The natural history of myopericarditis/perimyocarditis is poorly known and recently published data have presented contrasting 
results on their outcomes. The aim of the present article is to assess their prognosis in a multicenter, prospective cohort study.
methods: A total of 486 patients (median age 39 years, range 18-83, 300 men) with acute pericarditis or a myopericardial inflammatory syndrome 
(myopericarditis/perimyocarditis) (85% idiopathic, 10% autoimmune, and 5% infective) were prospectively evaluated from January 2007 to 
December 2011. Consecutive cases were recruited in 3 urban referral medical centres (Maria Vittoria Hospital, Torino, Ospedali Riuniti, Bergamo, 
and Policlinico, Modena, Italy). The diagnosis of acute pericarditis was based on the presence of 2 of 4 clinical criteria (chest pain, pericardial 
rubs, widespread ST-segment elevation or PR depression, and new or worsening pericardial effusion). Myopericardial inflammatory involvement was 
suspected with cardiac troponin elevation and/or new or worsening ventricular dysfunction on echocardiography, and confirmed by cardiac magnetic 
resonance.
results: After a median follow-up of 36 months (range 6-66), normalization of LV function was achieved in 90% of patients with myopericarditis/
perimyocarditis. No deaths were recorded, as well as evolution to heart failure or symptomatic LV dysfunction. Recurrences were the most common 
complications during follow-up and were more frequently recorded in patients with acute pericarditis (32%) than myopericarditis (11%) or 
perimyocarditis (12%;p<0.001). On multivariable analysis, pericardial effusion at presentation (HR 2.2) and corticosteroid therapy (HR 6.7) were 
risk factors for recurrences.
conclusions: The outcome of myopericardial inflammatory syndromes is benign. Unlike acute coronary syndromes, troponin elevation is not a 
negative prognostic marker in this setting.
